SecBot SecBot
EFFECT ·Filed Mar 23, 2026

COYA

Coya Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed7mo ago SEC9999999995-26-000895
IPO/offering going effective
Actionable Insight • Neutral

Traders should monitor for future prospectus supplements that will disclose specific offering terms, including size, price, and use of proceeds, which could signal near-term dilution or capital raising intent.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
COYA ▲ +19.19% at T+60d
NEUTRAL call +19.19% · α vs SPY +6.14% · entry $4.22 → $5.03
Entry = T+0 close
Mar 23, 2026
via day close
T+1d
-1.66%
call -1.66% · α -1.30%
$4.15
settled 7mo ago
T+5d
-10.43%
call -10.43% · α -6.86%
$3.78
settled 7mo ago
T+20d
+7.35%
call +7.35% · α -0.07%
$4.53
settled 6mo ago
T+60d
+19.19%
call +19.19% · α +6.14%
$5.03
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Coya Therapeutics, Inc. has had a Form S-3 shelf registration become effective, allowing the company to issue unspecified securities from time to time. This creates a potential for future share sales and possible dilution, though no specific offering details or amounts were disclosed.

Key Facts

  • Form S-3 shelf registration (File No. 333-294315) became effective on March 20, 2026.
  • The filing is a general-use shelf registration, permitting the company to issue unspecified securities in one or more offerings.
  • No specific offering size, pricing, or use of proceeds was disclosed in the EFFECT notice.
  • The company may now sell securities at its discretion, subject to market conditions.

Financial Impact

Potential future dilution depending on offering size and pricing, but no specific dollar amount or share count disclosed.

dilutionequitymarket_cap

Risk Factors

  • Potential for unexpected equity issuance leading to share dilution.
  • Market perception of a dilution overhang could pressure the stock price ahead of any actual offering.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000895
Document: 9999999995-26-000895-index.html9999999995-26-000895
Document: 9999999995-26-000895.txt9999999995-26-000895
8 reports for COYA
Performance horizon
Filters
Rows
Reports for COYA — sortable, filterable
TypeNow
Oct 14, 2026
13d ago
8-K
MIXED ★ 5/10
$4.18awaiting T+20—$4.12 (−1.44%)
Oct 5, 2026
22d ago
8-K
NEUTRAL ★ 4/10
$4.85awaiting T+20—$4.12 (−15.05%)
Sep 15, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$4.65 $4.48▼ −3.76%▼ −6.74%$4.12 (−11.40%)
Aug 11, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$4.80 $4.61▼ −3.96%▼ −2.90%$4.12 (−14.17%)
May 12, 2026
24w ago
8-K
NEUTRAL ★ 4/10
$4.29 $4.41▲ +2.80%▲ +4.52%$4.12 (−3.96%)
Apr 2, 2026
29w ago
8-K
NEUTRAL ★ 3/10
$4.01 $4.23▲ +5.49%▼ −4.39%$4.12 (+2.74%)
Mar 23, 2026
31w ago
EFFECT
NEUTRAL ★ 4/10
$4.22 $4.53▲ +7.35%▼ −0.07%$4.12 (−2.37%)
Mar 16, 2026
32w ago
S-3
NEUTRAL ★ 3/10
$4.50 $4.46▼ −0.89%▼ −4.67%$4.12 (−8.44%)
Showing 8 of 8

US Market Status

Market Closed — Opens Wed (15h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 23, 2026